This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnership Summit
March 21-23, 2023
Delivered as a Hybrid EventPhiladelphia Marriott Downtown

Kari Loeser
Vice President & Chief Compliance Officer at Cytokinetics


Kari is the Vice President and Chief Compliance Officer for Cytokinetics, Inc., where she provides executive management, direction, and oversight for all aspects of the compliance program, policies, monitoring, training, privacy, and brand-legal advisory. Previously, Kari was the US Healthcare Compliance and Privacy Officer and Senior Corporate Counsel at Vifor Pharma, Inc., and a Senior Director/Senior Compliance Counsel at Jazz Pharmaceuticals. She has extensive experience in providing legal and compliance advice on sales, marketing, promotional and medical materials review, Medical Affairs, managed care, commercial compliance, as well as U.S. Sunshine / aggregate spend and compliance operations.

Kari has published various articles and a book chapter on E-Health and Ethics, and she has presented at various conferences including the AHLA-HCCA Fraud and Abuse Conference and the Pharmaceutical Compliance Forum Annual Meeting. She authored an article in the International In-House Counsel Journal on client centricity and authored a book chapter in Cancer Policy: Pharmaceutical Safety entitled “Anatomy of Risk Evaluation and Mitigation Strategies (REMS)”, Springer Publishing (Germany), published in 2019.

Kari is a licensed attorney in Illinois and registered in-house counsel in California. She earned her J.D. from DePaul University College of Law, and her B.A. in Political Science and Religion with Honors from the University of Iowa.

Agenda Sessions

  • Setting Yourself Up for Success—Best Practices for a Successful Product Launch